Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer

por Wagner-Larsen, Kari S., Lura, Njål, Salvesen, Øyvind, Halle, Mari Kyllesø, Forsse, David, Trovik, Jone, Smit, Noeska, Krakstad, Camilla, Haldorsen, Ingfrid S.
Publicado 2022

What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?

por Lura, Njål, Wagner-Larsen, Kari S., Forsse, David, Trovik, Jone, Halle, Mari K., Bertelsen, Bjørn I., Salvesen, Øyvind, Woie, Kathrine, Krakstad, Camilla, Haldorsen, Ingfrid S.
Publicado 2022

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

por Kasius, Jenneke C., Pijnenborg, Johanna M. A., Lindemann, Kristina, Forsse, David, van Zwol, Judith, Kristensen, Gunnar B., Krakstad, Camilla, Werner, Henrica M. J., Amant, Frédéric
Publicado 2021

Preoperative pelvic MRI and 2-[(18)F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?

por Fasmer, Kristine E., Gulati, Ankush, Dybvik, Julie A., Wagner-Larsen, Kari S., Lura, Njål, Salvesen, Øyvind, Forsse, David, Trovik, Jone, Pijnenborg, Johanna M. A., Krakstad, Camilla, Haldorsen, Ingfrid S.
Publicado 2022

A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease

por Halle, Mari K., Sødal, Marte, Forsse, David, Engerud, Hilde, Woie, Kathrine, Lura, Njål G., Wagner-Larsen, Kari S., Trovik, Jone, Bertelsen, Bjørn I., Haldorsen, Ingfrid S., Ojesina, Akinyemi I., Krakstad, Camilla
Publicado 2021

A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival

por Halle, Mari K., Munk, Ane Cecilie, Engesæter, Birgit, Akbari, Saleha, Frafjord, Astri, Hoivik, Erling A., Forsse, David, Fasmer, Kristine E., Woie, Kathrine, Haldorsen, Ingfrid S., Bertelsen, Bjørn I., Janssen, Emiel A. M., Gudslaugsson, Einar, Krakstad, Camilla, Øvestad, Irene T.
Publicado 2021